IIT Madras-designed trial shows efficacy of Indomethacin drug in treating mild, moderate COVID-19 patients
The trials designed by the researchers at the Indian Institute of Technology (IIT) Madras have shown the excellent efficacy of Indomethacin, a non-steroidal anti-inflammatory drug as an antiviral agent in the treatment of mild and moderate COVID-19 patients.
Source: webindia123.com